Related Experiment Videos
Methodological aspects in the assessment of severity of depression by the Hamilton Depression Scale
1Department of Psychiatry Ludwig-Maximilians-University, Munich, Germany. hans-juergen.moeller@psy.med.uni-muenchen.de
Insights
The Hamilton Depression Scale (HAMD) total score may be biased in antidepressant trials. Using the HAMD 6-item score offers a fairer estimation of depression severity changes, particularly for newer antidepressants.
Area of Science:
- Psychiatry
- Clinical Psychology
- Psychopharmacology
Background:
- Observer-rating scales are crucial for evaluating depression drug trials.
- The Hamilton Depression Scale (HAMD) is a widely used but potentially biased instrument.
- Its construction may favor classical antidepressants.
Purpose of the Study:
- To investigate the methodological limitations of the HAMD total score.
- To propose and validate the use of the HAMD 6-item score as a more accurate efficacy criterion.
- To assess drug-induced changes in depression severity, avoiding known biases.
Main Methods:
- Methodological analyses including principal component analysis, Rasch model, and facet analysis.
- Differentiation between core depression severity symptoms and additional symptomatology.
- Evaluation of two sertraline-amitriptyline comparative studies.
Main Results:
- Methodological analyses suggest differentiating core and additional depression symptoms is meaningful.
- The HAMD 6-item score provides a fairer estimation of depression severity changes.
- This approach avoids the bias associated with the HAMD total score, favoring tricyclic antidepressants.
Conclusions:
- The HAMD 6-item score is a more reliable efficacy criterion in antidepressant drug trials.
- This refined approach offers a better assessment of drug effects on depression severity.
- It mitigates biases inherent in the traditional HAMD total score.
Abstract:
Observer-rating scales are used for the evaluation of drug trials in depression. One of the most widely used depression rating scales is still the Hamilton Depression Scale (HAMD), which was developed at the time when the first antidepressants were becoming available. Due to its construction it seems to have a specific focus on drug effects of classical antidepressants. As a result of different methodological analyses such as principal component analysis, the Rasch model and facet analysis, a differentiation between core symptoms reflecting the severity of depression and additional symptoms describing other aspects of the symptomatology of depression seems meaningful. The use of the HAMD 6-item score, described primarily by Bech, as the main efficacy criterion in antidepressant drug trials gives a fair estimation of drug-induced changes of severity of depression and avoids bias such as the well-known bias of the HAMD total score in favour of tricyclic antidepressants. This is demonstrated by the evaluation of two sertraline-amitriptyline comparative studies.